Combined phenotype of 4 markers improves prognostic value of patients with colon cancer

American Journal of the Medical Sciences

Volumn 343, Issue 4, 2012, Pages 295-302

  Liu, Caiyun ^a   Qu, Like ^a   Dong, Bin ^a   Xing, Xiaofang ^a   Ren, Tingting ^a   Zeng, Yan ^a   Jiang, Beihai ^a   Meng, Lin ^a   Wu, Jian ^a   Shou, Chengchao ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Colon cancer; Combined analysis; Immunochemistry; Lymph node metastasis

Indexed keywords

ARREST DEFECTIVE PROTEIN 1 HOMOLOG A; GAMMA SYNUCLEIN; HUMAN HOMOLOGUE OF PIWI; PHOSPHATASE; PHOSPHATASE OF REGENERATING LIVER 3; PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL FEATURE; COLON ADENOCARCINOMA; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN EXPRESSION;

EID: 84862776771     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31822cb4cd     Document Type: Article

References (45)

1. Eisenberg B, Decosse JJ, Harford F, et al. Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients. Cancer 1982;49:1131-4. (Pubitemid 12187812)
2. Hiratsuka M, Miyashiro I, Ishikawa O, et al. Application of sentinel node biopsy to gastric cancer surgery. Surgery 2001;129:335-40. (Pubitemid 32200064)
3. Buyse M, Piedbois P. Should Dukes' B patients receive adjuvant therapy? A statistical perspective. Semin Oncol 2001;28:20-4. (Pubitemid 32173100)
4. Eschrich S, Yang I, Bloom G, et al. Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 2005;23:3526-35.
5. Galizia G, Orditura M, Romano C, et al. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol 2002;102:169-78. (Pubitemid 34171516)
6. Zlobec I, Minoo P, Baumhoer D, et al. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer. Cancer 2008;112:495-502. (Pubitemid 351186190)
7. Uen YH, Lin SR, Wu DC, et al. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Ann Surg 2007;246:1040-6.
8. Liu H, Liu W, Wu Y, et al. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 2005;65:7635-43. (Pubitemid 41297236)
9. Jia T, Liu YE, Liu J, et al. Stimulation of breast cancer invasion and metastasis by synuclein gamma. Cancer Res 1999;59:742-7. (Pubitemid 29076076)
10. Inaba S, Li C, Shi YE, et al. Synuclein γ inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res Treat 2005;94:25-35. (Pubitemid 41416939)
11. Singh VK, Zhou Y, Marsh JA, et al. Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs. Cancer Res 2007;67:626-33. (Pubitemid 46192201)
12. Guo J, Shou C, Meng L, et al. Neuronal protein synuclein-γ predicts poor clinical outcome in breast cancer. Int J Cancer 2007;121:1296-305. (Pubitemid 47293797)
13. Wu K, Quan Z, Weng Z, et al. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis. Breast Cancer Res Treat 2007;101:259-67. (Pubitemid 46169879)
14. Liu C, Dong B, Lu A, et al. Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen. BMC Cancer 2010;10:359.
15. Hibi T, Mori T, Fukuma M, et al. Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer. Clin Cancer Res 2009;15:2864-71.
16. Qiao D, Zeeman AM, Deng W, et al. Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene 2002;21:3988-99. (Pubitemid 34679240)
17. Sharma AK, Nelson MC, Brandt JE, et al. Human CD34(+) stem cells express the hiwi gene, a human homologue of the Drosophila gene piwi. Blood 2001;97:426-34. (Pubitemid 32060327)
18. Li S, Meng L, Zhu C, et al. The universal overexpression of a cancer testis antigen hiwi is associated with cancer angiogenesis. Oncol Rep 2010;23:1063-8.
19. He W, Wang Z, Wang Q, et al. Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. BMC Cancer 2009;9:426.
20. Taubert H, Greither T, Kaushal D, et al. Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma. Oncogene 2007;26:1098-100.
21. Taubert H, Würl P, Greither T, et al. Stem cell-associated genes are extremely poor prognostic factors for soft-tissue sarcoma patients. Oncogene 2007;26:7170-4. (Pubitemid 350059682)
22. Zeng Q, Si X, Horstmann H, et al. Prenylation-dependent association of protein-tyrosine phosphatases PRL-1,-2, and-3 with the plasma membrane and the early endosome. J Biol Chem 2000;275:21444-52. (Pubitemid 30481847)
23. Sun JP, Wang WQ, Yang H, et al. Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion. Biochemistry 2005;44:12009-21. (Pubitemid 41285698)
24. Basak S, Jacobs SB, Krieg AJ, et al. The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation. Mol Cell 2008;30:303-14. (Pubitemid 351626943)
25. Zeng Q, Dong JM, Guo K, et al. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res 2003;63:2716-22. (Pubitemid 36667138)
26. Kato H, Semba S, Miskad UA, et al. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin Cancer Res 2004;10:7318-28. (Pubitemid 39487721)
27. Peng L, Ning J, Meng L, et al. The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer. J Cancer Res Clin Oncol 2004;130:521-6. (Pubitemid 39149883)
28. Radke I, Götte M, Kersting C, et al. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. Br J Cancer 2006;95:347-54. (Pubitemid 44187596)
29. Wang L, Peng L, Dong B, et al. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Ann Oncol 2006;17:1517-22. (Pubitemid 44542037)
30. Miskad UA, Semba S, Kato H, et al. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. Virchows Archiv 2007;450:303-10. (Pubitemid 46376561)
31. Li ZR, Wang Z, Zhu BH, et al. Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis. Surg Today 2007;37:646-51. (Pubitemid 47101246)
32. Fisher TS, Etages SD, Hayes L, et al. Analysis of ARD1 function in hypoxia response using retroviral RNA interference. J Biol Chem 2005;280:17749-57. (Pubitemid 41389013)
33. Lim JH, Park JW, Chun YS. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res 2006;66:10677-82.
34. Ohkawa N, Sugisaki S, Tokunaga E, et al. N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic development. Genes Cells 2008;13:1171-83.
35. Kuo HP, Hung MC. Arrest-defective-1 protein (ARD1): tumor suppressor or oncoprotein? Am J Transl Res 2010;2:56-64.
36. Yu M, Gong J, Ma M, et al. Immunohistochemical analysis of human arrest-defective-1 expressed in cancers in vivo. Oncol Rep 2009;21: 909-15.
37. Bilton R, Mazure N, Trottier E, et al. Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxiainducible factor (HIF)-1alpha and is not induced by hypoxia or HIF. J Biol Chem 2005;280:31132-40. (Pubitemid 41291849)
38. Liu C, Guo J, Qu L, et al. Applications of novel monoclonal antibodies specific for synuclein-γ in evaluating its levels in sera and cancer tissues from colorectal cancer patients. Cancer Lett 2008;269:148-58.
39. Liu X, Sun Y, Guo J, et al. Expression of hiwi gene in human gastric cancer was associated with proliferation of cancer cells. Int J Cancer 2006;118:1922-9.
40. Ren T, Jiang B, Jin G, et al. Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer. Cancer Lett 2008;264:83-92.
41. McLeod HL, Murray GI. Tumour markers of prognosis in colorectal cancer. Br J Cancer 1999;79:191-203. (Pubitemid 29002285)
42. Ricci-Vitiani L, Fabrizi E, Palio E, et al. Colon cancer stem cells. J Mol Med 2009;87:1097-104.
43. Boman BM, Wicha MS. Cancer stem cells: a step toward the cure. J Clin Oncol 2008;26:2795-9.
44. Miskad UA, Semba S, Kato H, et al. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Pathobiology 2004;71:176-84. (Pubitemid 38969875)
45. Yamashita S, Masuda Y, Matsumoto K, et al. Down-regulation of the human PRL-3 gene is associated with the metastasis of primary nonsmall cell lung cancer. Ann Thorac Cardiovasc Surg 2007;13:236-9.